Evidence map›Paper›PMID 28514277›Full record

Trial reportAIDS (London, England)2017

A commitment contract to achieve virologic suppression in poorly adherent patients with HIV/AIDS.

Marcella Alsan, John Beshears, Wendy S Armstrong, James J Choi, Brigitte C Madrian, Minh Ly T Nguyen, Carlos Del Rio, David Laibson, Vincent C Marconi

2 registry-linked trialsOpen access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in AIDS (London, England), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 15 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 3 pooled it
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01305590 nacompletednot on this map

Understanding Medication Adherence Among HIV Patients

TypeinterventionalSponsorNational Bureau of Economic Research, Inc.Ran2011 to 2011Enrolled200ConditionsPatient Commitment Preferences for Medication AdherenceArmsSurvey to Understand Medication Adherence among HIV Patients
NCT01455740 nacompletednot on this map

A Commitment Device for Medication Adherence Among HIV Patients

TypeinterventionalSponsorNational Bureau of Economic Research, Inc.Ran2011 to 2014Enrolled110ConditionsAcquired Immunodeficiency Syndrome, HIVArmsProvider Visit Incentive (PVI), Incentive Choice (IC)
3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 3 syntheses or guidelines pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Marcella AlsanaCenter for Health Policy and the Center for Primary Care and Outcomes Research, Stanford University, Stanford, California bNational Bureau of Economic Research, Cambridge, Massachusetts cNegotiation, Organizations & Markets Unit, Harvard Business School, Boston, Massachusetts dDivision of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia eSchool of Management, Yale University, New Haven, Connecticut fHarvard Kennedy School, Harvard University, Cambridge, Massachusetts gDepartment of Global Health, Rollins School of Public Health, Emory University, Atlanta, Georgia hDepartment of Economics, Harvard University, Cambridge, Massachusetts.
John Beshears
Wendy S Armstrong
James J Choi
Brigitte C Madrian
Minh Ly T Nguyen
Carlos Del Rio
David Laibson
Vincent C Marconi
Apple (Israel) · ILEmory University · USNational Bureau of Economic Research · USYale University · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Virology and Molecular Biomarkers CoreP30AI050409 · NIAID · EMORY UNIVERSITY · PI Carlos del Rio · 2002 to 2026
$74.0M
Pilot CoreP30AG034532 · NIA · NATIONAL BUREAU OF ECONOMIC RESEARCH · PI JOSEPH J DOYLE · 2009 to 2026
$10.2M
NCATS NIH HHS UL1 TR001863NIAID NIH HHS P30 AI050409NIA NIH HHS P30 AG034532
6 · The paper itself

Abstract

objectiveAssess whether a commitment contract informed by behavioral economics leads to persistent virologic suppression among HIV-positive patients with poor antiretroviral therapy (ART) adherence.

designSingle-center pilot randomized clinical trial and a nonrandomized control group.

settingPublicly funded HIV clinic in Atlanta, Georgia, USA.

interventionThe study involved three arms. First, participants in the provider visit incentive (PVI) arm received $30 after attending each scheduled provider visit. Second, participants in the incentive choice arm were given a choice between the above arrangement and a commitment contract that made the $30 payment conditional on both attending the provider visit and meeting an ART adherence threshold. Third, the passive control arm received routine care and no incentives.

participantsA total of 110 HIV-infected adults with a recent plasma HIV-1 viral load more than 200 copies/ml despite ART. The sample sizes of the three groups were as follows: PVI, n = 21; incentive choice, n = 19; and passive control, n = 70.

main outcome measureVirologic suppression (plasma HIV-1 viral load ≤200 copies/ml) at the end of the incentive period and at an unanticipated postincentive study visit approximately 3 months later.

resultsThe odds of suppression were higher in the incentive choice arm than in the passive control arm at the postincentive visit (adjusted odds ratio 3.93, 95% confidence interval 1.19-13.04, P = 0.025). The differences relative to the passive control arm at the end of the incentive period and relative to the PVI arm at both points in time were not statistically significant.

conclusionCommitment contracts can improve ART adherence and virologic suppression.

trial registrationClinicalTrials.gov identifier NCT01455740.

Indexed as

Medication AdherenceMotivationSustained Virologic ResponseAdultAgedAnti-HIV AgentsFemaleGeorgiaHIV InfectionsHumansMaleMiddle AgedPilot ProjectsTreatment OutcomeAnti-HIV Agents

Identifiers

PMID28514277
PMCPMC5897050
OpenAlexW2616054562

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.